» Articles » PMID: 26391946

Chronic Neuromotor Disability After Complex Cardiac Surgery in Early Life

Overview
Journal Pediatrics
Specialty Pediatrics
Date 2015 Sep 23
PMID 26391946
Citations 12
Authors
Affiliations
Soon will be listed here.
Abstract

Background And Objectives: Little is known about chronic neuromotor disability (CND) including cerebral palsy and motor impairments after acquired brain injury in children surviving early complex cardiac surgery (CCS). We sought to determine the frequency and presentation of CND in this population while exploring potentially modifiable acute care predictors.

Methods: This prospective follow-up study included 549 children after CCS requiring cardiopulmonary bypass at ≤6 weeks of age. Groups included those with only 1 CCS, mostly biventricular CHD, and those with >1 CCS, predominantly single ventricle defects. At 4.5 years of age, 420 (94.6%) children received multidisciplinary assessment. Frequency of CND is given as percentage of assessed survivors. Predictors of CND were analyzed using multiple logistic regression analysis.

Results: CND occurred in 6% (95% confidence interval [CI] 3.7%-8.2%) of 4.5-year survivors; for 1 CCS, 4.2% (CI 2.3%-6.1%) and >1, 9.8% (CI 7%-12.6%). CND presentation showed: hemiparesis, 72%; spasticity, 80%; ambulation, 72%; intellectual disability, 44%; autism, 16%; epilepsy, 12%; permanent vision and hearing impairment, 12% and 8%, respectively. Overall, 32% of presumed causative events happened before first CCS. Independent odds ratio for CND are age (days) at first CCS, 1.08 (CI 1.04-1.12; P < .001); highest plasma lactate before first CCS (mmol/L), 1.13 (CI 1.03-1.23; P = 0.008); and >1 CCS, 3.57 (CI 1.48-8.9; P = .005).

Conclusions: CND is not uncommon among CCS survivors. The frequency of associated disabilities characterized in this study informs pediatricians caring for this vulnerable population. Shortening the waiting period and reducing preoperative plasma lactate levels at first CCS may assist in reducing the frequency of CND.

Citing Articles

Comparing Neurodevelopmental Outcomes in Infants With Patent Ductus Arteriosus Stenting Versus Blalock-Taussig-Thomas Shunt: A Pilot Study.

El-Said H, Hussein A, Price K, Heibel J, Haley J, Haldeman S J Soc Cardiovasc Angiogr Interv. 2024; 3(5):101355.

PMID: 39132454 PMC: 11307534. DOI: 10.1016/j.jscai.2024.101355.


Association of congenital heart disease and neurodevelopmental disorders: an observational and Mendelian randomization study.

Liu Z, Wang Q, Pang X, Huang X, Yang G, Zhao S Ital J Pediatr. 2024; 50(1):63.

PMID: 38589916 PMC: 11003105. DOI: 10.1186/s13052-024-01610-3.


Association between Serum Lactate and Morbidity and Mortality in Neonates: A Systematic Review and Meta-Analysis.

Matsushita F, Krebs V, Brunow de Carvalho W Children (Basel). 2023; 10(11).

PMID: 38002887 PMC: 10670916. DOI: 10.3390/children10111796.


A phase II dose evaluation pilot feasibility randomized controlled trial of cholecalciferol in critically ill children with vitamin D deficiency (VITdAL-PICU study).

OHearn K, Menon K, Weiler H, Amrein K, Fergusson D, Gunz A BMC Pediatr. 2023; 23(1):397.

PMID: 37580663 PMC: 10424361. DOI: 10.1186/s12887-023-04205-9.


Infant Perioperative Risk Factors and Adverse Brain Findings Following Long-Gap Esophageal Atresia Repair.

Kagan M, Wang J, Pier D, Zurakowski D, Jennings R, Bajic D J Clin Med. 2023; 12(5).

PMID: 36902591 PMC: 10003188. DOI: 10.3390/jcm12051807.